Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda J Hooper

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
Journal of Pediatric Endocrinology & Metabolism : JPEM|July 3, 2026
Birth prevalence and characterisation of congenital hyperinsulinism in Western Australia over two decadesAdam J Stafford-Bell, Amanda J Hooper, Rachel Romans, et al.
International Journal of Cardiology|September 5, 2015
Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemiaDick C Chan, Jing Pang, Amanda J Hooper, et al.
Atherosclerosis|December 4, 2021
Cascade testing for elevated lipoprotein(a) in relatives of probands with familial hypercholesterolaemia and elevated lipoprotein(a)Anindita Chakraborty, Jing Pang, Dick C Chan, et al.
Clinical Biochemistry|February 27, 2016
Lipoprotein metabolism in an apoB-80 familial hypobetalipoproteinemia heterozygoteAmanda J Hooper, Ken Robertson, Danie Champain, et al.
Atherosclerosis|January 14, 2015
Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experienceDamon A Bell, Jing Pang, Sally Burrows, et al.
Pathology|April 12, 2020
Design, development and deployment of a web-based patient registry for rare genetic lipid disordersKathryn R Napier, Amanda J Hooper, David M Ng, et al.
Atherosclerosis|August 14, 2012
Genetic analysis of familial hypercholesterolaemia in Western AustraliaAmanda J Hooper, Lan T Nguyen, John R Burnett, et al.
Journal of Clinical Lipidology|June 23, 2022
A variant in the fibronectin (FN1) gene, rs1250229-T, is associated with decreased risk of coronary artery disease in familial hypercholesterolaemiaMichael M Page, Katrina L Ellis, Dick C Chan, et al.
Clinical Genetics|October 2, 2019
A genetic risk score predicts coronary artery disease in familial hypercholesterolaemia: enhancing the precision of risk assessmentKatrina L Ellis, Amanda J Hooper, Jing Pang, et al.
Journal of Clinical Apheresis|September 10, 2020
Lipoprotein apheresis and PCSK9 inhibitors for severe familial hypercholesterolaemia: Experience from Australia and New ZealandMichael M Page, Elif I Ekinci, John R Burnett, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Journal of Pediatric Endocrinology & Metabolism : JPEM|July 3, 2026
Birth prevalence and characterisation of congenital hyperinsulinism in Western Australia over two decadesAdam J Stafford-Bell, Amanda J Hooper, Rachel Romans, et al.
International Journal of Cardiology|September 5, 2015
Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemiaDick C Chan, Jing Pang, Amanda J Hooper, et al.
Atherosclerosis|December 4, 2021
Cascade testing for elevated lipoprotein(a) in relatives of probands with familial hypercholesterolaemia and elevated lipoprotein(a)Anindita Chakraborty, Jing Pang, Dick C Chan, et al.
Clinical Biochemistry|February 27, 2016
Lipoprotein metabolism in an apoB-80 familial hypobetalipoproteinemia heterozygoteAmanda J Hooper, Ken Robertson, Danie Champain, et al.
Atherosclerosis|January 14, 2015
Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experienceDamon A Bell, Jing Pang, Sally Burrows, et al.
Pathology|April 12, 2020
Design, development and deployment of a web-based patient registry for rare genetic lipid disordersKathryn R Napier, Amanda J Hooper, David M Ng, et al.
Atherosclerosis|August 14, 2012
Genetic analysis of familial hypercholesterolaemia in Western AustraliaAmanda J Hooper, Lan T Nguyen, John R Burnett, et al.
Journal of Clinical Lipidology|June 23, 2022
A variant in the fibronectin (FN1) gene, rs1250229-T, is associated with decreased risk of coronary artery disease in familial hypercholesterolaemiaMichael M Page, Katrina L Ellis, Dick C Chan, et al.
Clinical Genetics|October 2, 2019
A genetic risk score predicts coronary artery disease in familial hypercholesterolaemia: enhancing the precision of risk assessmentKatrina L Ellis, Amanda J Hooper, Jing Pang, et al.
Journal of Clinical Apheresis|September 10, 2020
Lipoprotein apheresis and PCSK9 inhibitors for severe familial hypercholesterolaemia: Experience from Australia and New ZealandMichael M Page, Elif I Ekinci, John R Burnett, et al.
Pageof 13